Show simple item record

dc.contributor.authorJin, D.
dc.contributor.authorRoskos, L.
dc.contributor.authorGuan, Y.
dc.contributor.authorZheng, Y.
dc.contributor.authorLiu, Y. H.
dc.contributor.authorChen, C.
dc.contributor.authorArmstrong, J.
dc.contributor.authorJiang, H.
dc.contributor.authorPaz-Ares, L.
dc.contributor.authorHochmair, M.
dc.contributor.authorHavel, L.
dc.contributor.authorChen, Y.
dc.contributor.authorPoltoratskiy, A.
dc.contributor.authorTrukhin, D.
dc.contributor.authorOzguroglu, M.
dc.date.accessioned2021-12-10T12:48:26Z
dc.date.available2021-12-10T12:48:26Z
dc.date.issued2021
dc.identifier.citationZheng Y., Jin D., Guan Y., Ozguroglu M., Trukhin D., Poltoratskiy A., Chen Y., Havel L., Hochmair M., Paz-Ares L., et al., "Population Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN", JOURNAL OF THORACIC ONCOLOGY, cilt.16, sa.3, 2021
dc.identifier.issn1556-0864
dc.identifier.otherav_d850589e-f48e-4553-87ac-8a979acacdaf
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/174708
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectHealth Sciences
dc.subjectPulmonary and Respiratory Medicine
dc.subjectRespiratory Care
dc.subjectOncology
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectSOLUNUM SİSTEMİ
dc.titlePopulation Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN
dc.typeMakale
dc.relation.journalJOURNAL OF THORACIC ONCOLOGY
dc.contributor.departmentAstrazeneca , ,
dc.identifier.volume16
dc.identifier.issue3
dc.contributor.firstauthorID2621997


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record